A retrospective analysis of early experience with a new approach to totally endoscopic aortic valve replacement in 266 patients showed satisfactory results, with acceptable morbidity and low mortality rates.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
February 9, 2023
February 9, 2023
Since the recent increase of TAVR to treat aortic valve disease, multidisciplinary heart teams consisting of surgeons, cardiologists, and other allied professionals have become a necessary component in a successful surgery.
February 9, 2023
The rate of serious complications in transcatheter aortic valve implantation (TAVI) has decreased markedly in recent years, going from 5.5 percent in 2012 to 2 percent in 2019. However, the total number of adverse events remains around 500, with about 100 requiring conversion to sternotomy, because of increased use of the procedure.
Minimally Invasive Versus Full Sternotomy for Isolated Aortic Valve Replacement in Low-Risk Patients
December 1, 2022
This comparison of minimally invasive versus full sternotomy surgical aortic valve replacement aimed to analyze outcomes of the two procedures for isolated surgery in patients enrolled in a low-risk trial. For this group of patients, it was found that the two approaches were associated with similar in-hospital and one-year outcomes.
October 13, 2022
Postoperative bleeding in patients undergoing cardiac surgery is a frequent problem, and this study aimed to test the contribution of metabolic perturbations to platelet dysfunction after cardiac surgery. Patients undergoing elective surgical aortic valve replacement were included in the study.
September 9, 2022
While transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic stenosis, a new study in the American Journal of Cardiology showed that there may be a high risk of in-hospital mortality for patients who undergo surgical aortic valve replacement (SAVR) after TAVR.
September 2, 2022
In the past, there has not been an accurate way to calculate mortality risk for patients with atrial fibrillation (AF) who have undergone a successful transcatheter aortic valve implantation (TAVI) and have been discharged home.
June 16, 2022
New findings published in the American Journal of Cardiology posit that transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) are associated with similar short-term outcomes among pediatric patients presenting with congenital heart disease (CHD).
Pulmonary homograft dysfunction after the Ross procedure using decellularized homografts—a multicenter study
April 9, 2022
This study from the Canadian Ross Registry evaluated 466 consecutive patients who underwent a Ross procedure using a decellularized cryopreserved pulmonary homograft and evaluated for pulmonary homograft dysfunction.
March 7, 2022
The Pediatric Cardiac Care Consortium was queried for patients undergoing repair of conotruncal abnormalities and subsequent AVR 1982 - 2003. Of 106 patients undergoing AVR, the operative mortality was 12%, and was related to infant age at the time of surgery (OR = 55). Transplant-free survival at 25 years was 53%. Transplant-free survival at 20